Articles
- 28Feb, 2022
The Journey from Bench to Market: Human Embryonic Stem Cells at Hadassah
The Journey from Bench to Market: Human Embryonic Stem Cells at Hadassah Hadasit subsidiary Cell Cure Neurosciences, via its parent company Lineage Cell Therapeutics, recently signed a deal with Roche…